Assessing the impact of psychotropic medication changes on challenging behavior of individuals with intellectual disabilities

References

• Aman, M. G., Burrow, W. H. and Wolford, P. L. (1995). The aberrant behavior checklist – community: Factor validity and effect of subject variables for adults in group homes. American Journal of Mental Deficiency, 100, 283–292.
   Google Scholar
• Bradley, E. A., Summers, J. A., Wood, H. L. and Bryson, S. E. (2004). Comparing rates of psychiatric and behavior disorders in adolescents and young adults with severe intellectual disability with and without autism. Journal of Autism & Developmental Disorders, 34, 151–161.
   Google Scholar
• Brylewski, J. and Duggan, L. (1999). Antipsychotic medication for challenging behaviour in people with intellectual disability: A systematic review of randomized controlled trials. Journal of Intellectual Disability Research, 43, 360–371.
   Google Scholar
• Buoli, M., Serati, M. and Altamura, A. C. (2013). Is the combination of a mood stabilizer plus an antipsychotic more effective than mono-therapies in long-term treatment of bipolar disorder? A systematic review. Journal of Affective Disorders, 152–154, 12–18.
   Google Scholar
• Cox, A. D. and Virues-Ortega, J. (2015). Interactions between behavior function and psychotropic medication. Journal of Applied Behavior Analysis, 48, 1–20.
   Google Scholar
• Crosland, K. A., Zarcone, J. R., Lindauer, S. E., Valdovinos, M. G., Zarcone, T. J., Hellings, J. A. and Schroeder, S. R. (2003). Use of functional analysis methodology in the evaluation of medication effects. Journal of Autism and Developmental Disorders, 33, 271–279.10.1023/A:1024402500425
   Google Scholar
• Deb, S. and Joyce, J. (1998). Psychiatric illness and behavioural problems in adults with learning disability and epilepsy. Behavioural Neurology, 11, 125–129.
   Google Scholar
• Deb, S., Kwok, H., Bertelli, M., Salvador-Carulla, L., Bradley, E., Torr, J. and Barnhill, J. (2009). International guide to prescribing psychotropic medication for the management of problem behaviours in adults with intellectual disabilities. World Psychiatry, 8, 181–186.10.1002/wps.2009.8.issue-3
   Google Scholar
• Deb, S. S., Sohanpal, S. K., Soni, R. R., Lentre, L. L. and Unwin, G. G. (2007). The effectiveness of antipsychotic medication in the management of behaviour problems in adults with intellectual disabilities. Journal of Intellectual Disability Research, 51, 766–777.10.1111/jir.2007.51.issue-10
   Google Scholar
• Deb, S., Unwin, G. and Deb, T. (2015). Characteristics and the trajectory of psychotropic medication use in general and antipsychotics in particular among adults with an intellectual disability who exhibit aggressive behaviour. Journal of Intellectual Disability Research, 59, 11–25.10.1111/jir.12119
   Google Scholar
• Expert consensus guidelines series. (2000). Treatment of psychiatric and behavioral problems in mental retardation. American Journal on Mental Retardation, 105, 159–226.
   Google Scholar
• Hammond, J. L., Iwata, B. A., Rooker, G. W., Fritz, J. N. and Bloom, S. E. (2013). Effects of fixed versus random condition sequencing during multielement functional analyses. Journal of Applied Behavior Analysis, 46, 22–30.10.1002/jaba.v46.1
   Google Scholar
• Healy, O., Brett, D. and Leader, G. (2013). A comparison of experimental functional analysis and the questions about behavioral function (QABF) in the assessment of challenging behavior of individuals with autism. Research in Autism Spectrum Disorders, 7, 66–81.10.1016/j.rasd.2012.05.006
   Google Scholar
• Hellings, J. A., Boehm, D., Yeh, H. W., Butler, M. G. and Schroeder, S. R. (2011). Long-term aripiprazole in youth with developmental disabilities including autism. Journal of Mental Health Research in Intellectual Disabilities, 4, 40–52.10.1080/19315864.2010.542274
   Google Scholar
• Hїβler, F., Thome, J. and Reis, O. (2015). Polypharmacy in the treatment of subjects with intellectual disability. Journal of Neural Transmission, 122(Suppl 1), S93–S100.
   Google Scholar
• Hurley, A. D., Reiss, S., Aman, M. G., Salvador-Carulla, L., Demb, H., Loschen, E. and Einfeld, S. (1998). Instruments for assessing effects of psychotropic medication. In: S. Reiss and M. G. Aman (eds.) Psychotropic medications and developmental disabilities: The international consensus handbook. Columbus, OH: Nisonger Center for Mental Retardation and Developmental Disabilities: The Ohio State University., pp. 85–94.
   Google Scholar
• Iwata, B. A., Dorsey, M. F., Slifer, K. J., Bauman, K. E. and Richman, G. S. (1994). Toward a functional analysis of self-injury. Journal of Applied Behavior Analysis, 27, 197–209.10.1901/jaba.1994.27-197
   Google Scholar
• LaRue, R. H., Jr, Northup, J., Baumeister, A. A., Hawkins, M. F., Seale, L., Williams, T. and Ridgway, A. (2008). An evaluation of stimulant medication on the reinforcing effects of play. Journal of Applied Behavior Analysis, 41, 143–147.10.1901/jaba.2008.41-143
   Google Scholar
• Madsen, E. K., Peck, J. A. and Valdovinos, M. G. (2015). A review of research on direct-care staff data collection regarding the severity and function of challenging behavior in individuals with intellectual and developmental disabilities. Journal of Intellectual Disabilities Epub ahead of print. doi: 10.1177/1744629515612328
   Google Scholar
• Matson, J. L. and Neal, D. (2009). Psychotropic medication use for challenging behaviors in persons with intellectual disabilities: An overview. Research in Developmental Disabilities, 30, 572–586.10.1016/j.ridd.2008.08.007
   Google Scholar
• Matson, J. L. and Rivet, T. T. (2008). Characteristics of challenging behaviours in adults with autistic disorder, PDD-NOS, and intellectual disability. Journal of Intellectual & Developmental Disability, 33, 323–329.
   Google Scholar
• Northup, J., Fusilier, I., Swanson, V., Roane, H. and Borrero, J. (1997). An evaluation of methylphenidate as a potential establishing operation for some common classroom reinforcers. Journal of Applied Behavior Analysis, 30, 615–625.10.1901/jaba.1997.30-615
   Google Scholar
• Northup, J., Fusilier, I., Swanson, V., Huete, J., Bruce, T., Freeland, J., Gulley, V. and Edwards, S. (1999). Further analysis of the separate and interactive effects of methylphenidate and common classroom contingencies. Journal of Applied Behavior Analysis, 32, 35–50.10.1901/jaba.1999.32-35
   Google Scholar
• O’Neill, R. E., Horner, R. H., Albin, R. W., Sprague, J. R., Storey, K. and Newton, J. S. (1997). Functional assessment and program development for problem behavior. Pacific Grove, CA: Brooks/Cole Publishing.
   Google Scholar
• Paclawskyj, T. R., Matson, J. L., Rush, K. S., Smalls, Y. and Vollmer, T. R. (2000). Questions about behavioral function (QABF). Research in Developmental Disabilities, 21, 223–229.10.1016/S0891-4222(00)00036-6
   Google Scholar
• Paclawskyj, T. R., Matson, J. L., Rush, K. S., Smalls, Y. and Vollmer, T. R. (2001). Assessment of the convergent validity of the questions about behavioral function scale with analogue functional analysis and the motivation assessment scale. Journal of Intellectual Disability Research, 45, 484–494.10.1046/j.1365-2788.2001.00364.x
   Google Scholar
• Ruedrich, S. L., Swales, T. P., Rossvanes, C., Diana, L., Arkadiev, V. and Lim, K. (2008). Atypical antipsychotic medication improves aggression, not self-injurious behaviour, in adults with intellectual disabilities. Journal of Intellectual Disability Research, 52, 132–140.
   Google Scholar
• Sheehan, R., Hassiotis, A., Walters, K., Osborn, D., Strydom, A. and Horsfall, L. (2015). Mental illness, challenging behaviour, and psychotropic drug prescribing in people with intellectual disability: UK population based cohort study. BMJ, 351, h4326–9.10.1136/bmj.h4326
   Google Scholar
• Stortz, J. N., Lake, J. K., Cobigo, V., Ouellette-Kuntz, H. M. J. and Lunsky, Y. (2014). Lessons learned from our elders: How to study polypharmacy in populations with intellectual and developmental disabilities. Intellectual and Developmental Disabilities, 52, 60–77.10.1352/1934-9556-52.1.60
   Google Scholar
• Tarbox, J., Wilke, A. E., Najdowski, A. C., Findel-Pyles, R. S., Balasanyan, S. and Tia, B. (2009). Comparing indirect, descriptive, and experimental functional assessments of challenging behavior in children with autism. Journal of Developmental and Physical Disabilities, 21, 493–514.10.1007/s10882-009-9154-8
   Google Scholar
• Tsakanikos, E., Costello, H., Holt, G., Sturmey, P. and Bouras, N. (2007). Behaviour management problems as predictors of psychotropic medication and use of psychiatric services in adults with autism. Journal of Autism and Developmental Disorders, 37, 1080–1085.10.1007/s10803-006-0248-1
   Google Scholar
• Tsiouris, J. A., Kim, S.-Y., Brown, W. T., Pettinger, J. and Cohen, I. L. (2013). Prevalence of psychotropic drug use in adults with intellectual disability: Positive and negative findings from a large scale study. Journal of Autism and Developmental Disorders, 43, 719–731.10.1007/s10803-012-1617-6
   Google Scholar
• Tyrer, P., Oliver-Africano, P. C., Ahmed, Z., Bouras, N., Cooray, S., Deb, S., Murphy, D., Hare, M., Meade, M., Reece, B., Kramo, K., Bhaumik, S., Harley, D., Regan, A., Thomas, D., Rao, B., North, B., Eliahoo, J., Karatela, S., Soni, A., & Crawford, M. (2008). Risperidone, haloperidol, and placebo in the treatment of aggressive challenging behaviour in patients with intellectual disability: A randomised controlled trial. The Lancet, 371, 57–63. doi:10.1016/S0140-6736(08)60072-0
   Google Scholar
• Unwin, G. L. and Deb, S. (2011). Efficacy of atypical antipsychotic medication in the management of behaviour problems in children with intellectual disabilities and borderline intelligence: A systematic review. Research in Developmental Disabilities, 32, 2121–2133.10.1016/j.ridd.2011.07.031
   Google Scholar
• Valdovinos, M. G., Ellringer, N. P. and Alexander, M. L. (2007). Changes in the rate of problem behavior associated with the removal of the antipsychotic medication quetiapine. Mental Health Aspects of Developmental Disabilities, 10, 64–67.
   Google Scholar
• Valdovinos, M. G., Nelson, S. M., Kuhle, J. and Dierks, A. M. (2009). Using analogue functional analysis to measure variations in problem behavior rate and function after psychotropic medication changes: A clinical demonstration. Journal of Mental Health Research in Intellectual Disabilities, 2, 279–293.10.1080/19315860903104807
   Google Scholar
• Valdovinos, M. G., Schroeder, S. R. and Kim, G. (2003). Prevalence and correlates of psychotropic medication use among adults with developmental disabilities: 1970–2000. International Review of Research in Mental Retardation, 26, 175–220.10.1016/S0074-7750(03)01005-X
   Google Scholar
• Weeden, M., Erhardt, K. and Poling, A. (2010). Psychotropic drug treatments for people with Autism and other developmental disorders: A primer for practicing behavior analysts. Behavior Analysis in Practice, 3, 4–12.
   Google Scholar
• Willams, H., Clarke, R., Bouras, N., Martin, J. and Holt, G. (2000). Use of the atypical antipsychotics olanzapine and risperidone in adults with intellectual disability. Journal of Intellectual Disability Research, 44, 164–169.
   Google Scholar
• Zarcone, J. R., Lindauer, S. L., Morse, P. S., Crosland, K. A., Valdovinos, M. G., McKerchar, T. L., Matthew Reese, R. M., Hellings, J. A. and Schroeder, S. R. (2004). Effects of risperidone on destructive behavior of persons with developmental disabilities: III. Functional analysis. American Journal on Mental Retardation, 109, 310–321.10.1352/0895-8017(2004)109<310:EORODB>2.0.CO;2
   Google Scholar